Alex Thompson

Stock Analyst at Stifel

(0)
# 4882
Out of 5,358 analysts
44
Total ratings
31.58%
Success rate
-23.56%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
KYMR Kymera Therapeutics
Reinstates: Buy
55
47.64 15.45% 1 May 20, 2025
TVTX Travere Therapeutics
Maintains: Hold
22 23
15.31 50.23% 3 May 2, 2025
THRD Third Harmonic Bio
Downgrades: Hold
23 5
5.29 -5.48% 2 Mar 28, 2025
AVTX Avalo Therapeutics
Initiates Coverage On: Buy
36
4.12 773.79% 1 Mar 25, 2025
CRNX Crinetics Pharmaceut...
Initiates Coverage On: Buy
60
33 81.82% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
200 207
173.15 19.55% 2 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
30 57
n/a n/a 4 Jul 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
485 500
585.97 -14.67% 4 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
36 54
16.95 218.58% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
44
18.83 133.67% 1 Feb 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
6 2
2.45 -18.37% 5 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
66 69
46.78 47.5% 2 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.53 -34.64% 4 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40
14.7 172.11% 2 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
1.18 3289.83% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
28 34
16.77 102.74% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
43 41
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
1.62 1937.04% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
37
n/a n/a 1 Sep 7, 2022